APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sprycel

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sprycel Market Outlook and Growth Opportunities 2026

Report ID 174037570422 December 2025196 pages

Choose your research edition.

Industry ResearchSprycel Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Sprycel Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Sprycel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sprycel Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sprycel Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Sprycel market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sprycel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sprycel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sprycel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sprycel market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sprycel market include Bristol-Myers Squibb and LUCIUS Pharma among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sprycel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sprycel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sprycel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sprycel market size, projected growth trends, production technologies, key applications, and end-use industries.

Sprycel Segment by Company

Bristol-Myers Squibb

LUCIUS Pharma

Sprycel Segment by Type

70mg

50mg

20mg

Sprycel Segment by Application

CML

ALL

Sprycel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sprycel status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sprycel market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sprycel significant trends, drivers, influence factors in global and regions.

6. To analyze Sprycel competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sprycel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sprycel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sprycel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sprycel market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sprycel industry.

Chapter 3: Detailed analysis of Sprycel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sprycel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sprycel in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sprycel Industry Trends Table 2. Sprycel Industry Drivers Table 3. Sprycel Industry Opportunities and Challenges Table 4. Sprycel Industry Restraints Table 5. Global Sprycel Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sprycel Revenue Share by Company (2021-2026) Table 7. Global Sprycel Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sprycel Sales Volume Share by Company (2021-2026) Table 9. Global Sprycel Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sprycel Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sprycel Key Company Manufacturing Base & Headquarters Table 12. Global Sprycel Company, Product Type & Application Table 13. Global Sprycel Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sprycel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 70mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of 20mg Table 20. Global Sprycel Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Sprycel Sales Volume by Type (2021-2026) & (k units) Table 22. Global Sprycel Sales Volume by Type (2027-2032) & (k units) Table 23. Global Sprycel Sales Volume Share by Type (2021-2026) Table 24. Global Sprycel Sales Volume Share by Type (2027-2032) Table 25. Global Sprycel Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sprycel Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sprycel Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sprycel Sales Value Share by Type (2021-2026) Table 29. Global Sprycel Sales Value Share by Type (2027-2032) Table 30. Significant Companies of CML Table 31. Significant Companies of ALL Table 32. Global Sprycel Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Sprycel Sales Volume by Application (2021-2026) & (k units) Table 34. Global Sprycel Sales Volume by Application (2027-2032) & (k units) Table 35. Global Sprycel Sales Volume Share by Application (2021-2026) Table 36. Global Sprycel Sales Volume Share by Application (2027-2032) Table 37. Global Sprycel Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sprycel Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sprycel Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sprycel Sales Value Share by Application (2021-2026) Table 41. Global Sprycel Sales Value Share by Application (2027-2032) Table 42. Global Sprycel Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Sprycel Sales by Region (2021-2026) & (k units) Table 44. Global Sprycel Sales Market Share by Region (2021-2026) Table 45. Global Sprycel Sales by Region (2027-2032) & (k units) Table 46. Global Sprycel Sales Market Share by Region (2027-2032) Table 47. Global Sprycel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sprycel Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sprycel Sales Value Share by Region (2021-2026) Table 50. Global Sprycel Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sprycel Sales Value Share by Region (2027-2032) Table 52. Global Sprycel Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Sprycel Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Sprycel Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Sprycel Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sprycel Sales by Country (2021-2026) & (k units) Table 57. Global Sprycel Sales Market Share by Country (2021-2026) Table 58. Global Sprycel Sales by Country (2027-2032) & (k units) Table 59. Global Sprycel Sales Market Share by Country (2027-2032) Table 60. Global Sprycel Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sprycel Sales Value Market Share by Country (2021-2026) Table 62. Global Sprycel Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sprycel Sales Value Market Share by Country (2027-2032) Table 64. Bristol-Myers Squibb Company Information Table 65. Bristol-Myers Squibb Business Overview Table 66. Bristol-Myers Squibb Sprycel Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Bristol-Myers Squibb Sprycel Product Portfolio Table 68. Bristol-Myers Squibb Recent Development Table 69. LUCIUS Pharma Company Information Table 70. LUCIUS Pharma Business Overview Table 71. LUCIUS Pharma Sprycel Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. LUCIUS Pharma Sprycel Product Portfolio Table 73. LUCIUS Pharma Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Sprycel Distributors List Table 77. Sprycel Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Sprycel Product Image Figure 2. Global Sprycel Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sprycel Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sprycel Sales (2021-2032) & (k units) Figure 5. Global Sprycel Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sprycel Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 70mg Image Figure 10. 50mg Image Figure 11. 20mg Image Figure 12. Global Sprycel Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Sprycel Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sprycel Sales Volume Share by Type (2021-2032) Figure 15. Global Sprycel Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sprycel Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sprycel Sales Value Share by Type (2021-2032) Figure 18. CML Image Figure 19. ALL Image Figure 20. Global Sprycel Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Sprycel Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sprycel Sales Volume Share by Application (2021-2032) Figure 23. Global Sprycel Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sprycel Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sprycel Sales Value Share by Application (2021-2032) Figure 26. Global Sprycel Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Sprycel Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sprycel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sprycel Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sprycel Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sprycel Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sprycel Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sprycel Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sprycel Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sprycel Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sprycel Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sprycel Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sprycel Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sprycel Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sprycel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sprycel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sprycel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sprycel Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sprycel Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 70mg
  • 50mg
  • 20mg
Applications
  • CML
  • ALL
Companies covered
  • Bristol-Myers Squibb
  • LUCIUS Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sprycel Sales Value (2021-2032)
  4. 1.2.2 Global Sprycel Sales Volume (2021-2032)
  5. 1.2.3 Global Sprycel Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sprycel Market Dynamics
  1. 2.1 Sprycel Industry Trends
  2. 2.2 Sprycel Industry Drivers
  3. 2.3 Sprycel Industry Opportunities and Challenges
  4. 2.4 Sprycel Industry Restraints
3 Sprycel Market by Company
  1. 3.1 Global Sprycel Company Revenue Ranking in 2025
  2. 3.2 Global Sprycel Revenue by Company (2021-2026)
  3. 3.3 Global Sprycel Sales Volume by Company (2021-2026)
  4. 3.4 Global Sprycel Average Price by Company (2021-2026)
  5. 3.5 Global Sprycel Company Ranking (2024-2026)
  6. 3.6 Global Sprycel Company Manufacturing Base and Headquarters
  7. 3.7 Global Sprycel Company Product Type and Application
  8. 3.8 Global Sprycel Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sprycel Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sprycel Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sprycel Market by Type
  1. 4.1 Sprycel Type Introduction
  2. 4.1.1 70mg
  3. 4.1.2 50mg
  4. 4.1.3 20mg
  5. 4.2 Global Sprycel Sales Volume by Type
  6. 4.2.1 Global Sprycel Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sprycel Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sprycel Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sprycel Sales Value by Type
  10. 4.3.1 Global Sprycel Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sprycel Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sprycel Sales Value Share by Type (2021-2032)
5 Sprycel Market by Application
  1. 5.1 Sprycel Application Introduction
  2. 5.1.1 CML
  3. 5.1.2 ALL
  4. 5.2 Global Sprycel Sales Volume by Application
  5. 5.2.1 Global Sprycel Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sprycel Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sprycel Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sprycel Sales Value by Application
  9. 5.3.1 Global Sprycel Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sprycel Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sprycel Sales Value Share by Application (2021-2032)
6 Sprycel Regional Sales and Value Analysis
  1. 6.1 Global Sprycel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sprycel Sales by Region (2021-2032)
  3. 6.2.1 Global Sprycel Sales by Region: 2021-2026
  4. 6.2.2 Global Sprycel Sales by Region (2027-2032)
  5. 6.3 Global Sprycel Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sprycel Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sprycel Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sprycel Sales Value by Region (2027-2032)
  9. 6.5 Global Sprycel Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sprycel Sales Value (2021-2032)
  12. 6.6.2 North America Sprycel Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sprycel Sales Value (2021-2032)
  15. 6.7.2 Europe Sprycel Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sprycel Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sprycel Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sprycel Sales Value (2021-2032)
  21. 6.9.2 South America Sprycel Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sprycel Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sprycel Sales Value Share by Country, 2025 VS 2032
7 Sprycel Country-level Sales and Value Analysis
  1. 7.1 Global Sprycel Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sprycel Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sprycel Sales by Country (2021-2032)
  4. 7.3.1 Global Sprycel Sales by Country (2021-2026)
  5. 7.3.2 Global Sprycel Sales by Country (2027-2032)
  6. 7.4 Global Sprycel Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sprycel Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sprycel Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sprycel Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sprycel Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sprycel Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sprycel Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sprycel Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sprycel Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sprycel Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sprycel Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sprycel Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sprycel Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sprycel Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sprycel Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sprycel Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sprycel Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sprycel Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sprycel Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sprycel Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sprycel Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sprycel Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sprycel Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sprycel Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sprycel Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sprycel Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sprycel Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sprycel Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sprycel Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sprycel Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sprycel Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sprycel Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sprycel Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sprycel Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sprycel Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sprycel Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sprycel Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sprycel Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sprycel Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sprycel Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sprycel Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sprycel Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sprycel Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sprycel Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sprycel Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sprycel Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sprycel Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sprycel Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sprycel Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sprycel Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sprycel Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sprycel Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sprycel Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sprycel Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sprycel Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sprycel Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sprycel Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sprycel Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sprycel Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sprycel Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sprycel Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sprycel Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sprycel Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sprycel Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sprycel Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sprycel Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sprycel Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sprycel Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sprycel Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sprycel Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sprycel Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sprycel Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sprycel Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sprycel Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sprycel Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sprycel Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sprycel Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sprycel Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sprycel Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sprycel Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sprycel Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sprycel Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sprycel Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sprycel Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sprycel Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sprycel Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sprycel Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol-Myers Squibb
  2. 8.1.1 Bristol-Myers Squibb Company Information
  3. 8.1.2 Bristol-Myers Squibb Business Overview
  4. 8.1.3 Bristol-Myers Squibb Sprycel Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bristol-Myers Squibb Sprycel Product Portfolio
  6. 8.1.5 Bristol-Myers Squibb Recent Developments
  7. 8.2 LUCIUS Pharma
  8. 8.2.1 LUCIUS Pharma Company Information
  9. 8.2.2 LUCIUS Pharma Business Overview
  10. 8.2.3 LUCIUS Pharma Sprycel Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 LUCIUS Pharma Sprycel Product Portfolio
  12. 8.2.5 LUCIUS Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sprycel Value Chain Analysis
  2. 9.1.1 Sprycel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sprycel Sales Mode & Process
  6. 9.2 Sprycel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sprycel Distributors
  9. 9.2.3 Sprycel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst